Antipanic efficacy of paroxetine and polymorphism within the promoter of the serotonin transporter gene.
about
Lack of association between the Serotonin Transporter Promoter Polymorphism (5-HTTLPR) and Panic Disorder: a systematic review and meta-analysisBiological predictors of pharmacological therapy in anxiety disordersNovel Primate Model of Serotonin Transporter Genetic Polymorphisms Associated with Gene Expression, Anxiety and Sensitivity to Antidepressants.A dimensional approach to modeling symptoms of neuropsychiatric disorders in the marmoset monkey.Biological markers for anxiety disorders, OCD and PTSD - a consensus statement. Part I: Neuroimaging and genetics.A neurobiological hypothesis of treatment-resistant depression - mechanisms for selective serotonin reuptake inhibitor non-efficacy.Understanding the pharmacogenetics of selective serotonin reuptake inhibitors.Serotonin pathway polymorphisms and the treatment of major depressive disorder and anxiety disorders.Genetic polymorphisms in monoamine systems and outcome of cognitive behavior therapy for social anxiety disorder.Association of Anxiety Symptoms in Offspring of Bipolar Parents with Serotonin Transporter-Linked Polymorphic Region (5-HTTLPR) Genotype.Predicting Response Trajectories during Cognitive-Behavioural Therapy for Panic Disorder: No Association with the BDNF Gene or Childhood Maltreatment.Serotonin function in panic disorder: important, but why?Advances in molecular genetics of panic disorder.Genetics of panic disorder: focus on association studies and therapeutic perspectives.Pharmacogenetics of antidepressant drugs: current clinical practice and future directions.Clinical validity of cytochrome P450 metabolism and serotonin gene variants in psychiatric pharmacotherapy.Novel investigational therapeutics for panic disorder.Clinical and genetic outcome determinants of Internet- and group-based cognitive behavior therapy for social anxiety disorder.Interaction between polymorphisms in serotonin transporter (SLC6A4) and serotonin receptor 2A (HTR2A) genes predict treatment response to venlafaxine XR in generalized anxiety disorder.Early Improvement and Marriage Are Determinants of the 12-Month Treatment Outcome of Paroxetine in Outpatients with Panic Disorder.Menopausal status could modulate the association between 5-HTTLPR and antidepressant efficacy in depressed women: a pilot study.Genetic moderation of CO2-induced fear by 5-HTTLPR genotype.Association study of paroxetine therapeutic response with SERT gene polymorphisms in patients with major depressive disorder.
P2860
Q21093204-5FE6362B-1BB5-4039-B043-116BC4CCA4DDQ26781100-8D379DC4-C492-4ED6-A80D-FF4DA265D103Q27310483-0C914042-BB8D-4C0F-B25E-A87B7AFE16C9Q30356275-36BADE56-A4E5-448C-B6FD-AA6E2BD0E01FQ31114020-C60D1782-64D4-4C73-A0F5-90E19FB53DD1Q33658525-4B18F5B4-0AA4-4791-A522-A2C49F3F4837Q34424865-7A4CDD0D-9152-4BCC-A664-BA730D63325EQ34473840-C411F9A6-B7DF-443E-9465-D4A9486FB1F2Q35048160-94742979-69B9-4F34-A896-3CA72353F2B6Q35984750-066ACD2C-347F-44DF-95A6-1027788425CBQ36063778-F1C2E32D-1753-4354-921C-F454C4A830DFQ36244896-4A4DF1EB-E608-43DD-B006-2712571FE268Q37667843-B6D12E6A-978F-488E-BFE7-8CB16B6A7FABQ37775989-10FF6CA5-1121-4A45-A2E6-DEEA2A8A9502Q37989490-33C17191-FB01-45B2-A54C-307D94131215Q38154911-27E6C7DD-6E21-48AB-B3E2-7912E3F25555Q38300166-4D306ABE-FBDC-472F-8670-8EC66F21D41EQ43612210-E6C9E133-6402-4A01-97E4-A38488EE0D0CQ46821332-9DB8C4A4-A577-4F08-BBEA-9331D648EE77Q47163599-64BDC142-CE88-4204-A3B5-2024A6820F56Q48204259-E50A2822-C714-47DF-B960-B31607985391Q50684019-E7FDBD4B-8480-472F-8767-660CB5BB7B61Q51899390-5BB43861-CD9D-4474-B04D-1ED5BD44E1DC
P2860
Antipanic efficacy of paroxetine and polymorphism within the promoter of the serotonin transporter gene.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Antipanic efficacy of paroxeti ...... he serotonin transporter gene.
@en
Antipanic efficacy of paroxeti ...... he serotonin transporter gene.
@nl
type
label
Antipanic efficacy of paroxeti ...... he serotonin transporter gene.
@en
Antipanic efficacy of paroxeti ...... he serotonin transporter gene.
@nl
prefLabel
Antipanic efficacy of paroxeti ...... he serotonin transporter gene.
@en
Antipanic efficacy of paroxeti ...... he serotonin transporter gene.
@nl
P2093
P2860
P356
P1476
Antipanic efficacy of paroxeti ...... he serotonin transporter gene.
@en
P2093
Elisa Favaron
Laura Bellodi
Riccardo Bussi
P2860
P2888
P304
P356
10.1038/SJ.NPP.1300822
P407
P577
2005-12-01T00:00:00Z